Table 2

Results of the FDG-PET and CMR studies in patients with CS

CharacteristicsConventional active group (n=33)Conventional inactive group (n=7)P value
FDG-PET positive, n (%)23 (70)2 (29)0.06
T2W-STIR-BB in CMR positive by quantitative analysis using MSR, n (%)26 (79)4 (57)0.23
T2W-STIR-BB in CMR positive by visual analysis, n (%)21 (64)4 (57)0.53
LGE in CMR compatible with CS positive, n (%)32 (100)6 (100)1.0
  • CMR, cardiac magnetic resonance; CS, cardiac sarcoidosis; FDG-PET, 18F-fluoro-2-deoxyglucose positron emission tomography; LGE, late gadolinium enhancement; MSR, myocardium-to-spleen ratio; T2W-STIR-BB, T2-weighted short-tau-inversion-recovery black-blood.